There is a great need for sensitive, precise, and easily accessible analytical detection techniques for protein sequencing.

Biologics Quality Control: The Growing Need for Accessible Proteomics

The emergence of mRNA vaccines and cell and gene therapies has pushed innovation in analytical methods.

Emerging Therapies Drive Analytical Advancements

Effective analytics will eliminate failures, deviations, and non-conformances.

 Analyzing Exabytes

Topic

Articles

GEA's self-contained homogenizer is designed for laboratory applications, including cell dispersions.

Self-Contained Laboratory Homogenizer Prepares Injectable Drugs

Geoff Carr is the Director of Analytical Development at Patheon located in Mississauga, Ontario. His email is geoff.carr@patheon.com.

A study of root cause in stability samples suggests the need for tighter control of the sodium lauryl sulfate manufacturing processes.

Black Specks in Tablet Stability Samples

Shimadzu’s LCMS-8060 triple quadrupole mass spectrometer is designed for LC/MS/MS quantitation of highly sensitive applications.

Mass Spectrometer Improves Efficiency

After a long wait for the new elemental impurities guidelines, the bio/pharma industry must now look ahead to implementation and take action.

Moving On to Implementation for Elemental Impurities Testing

SafeBridge Consultants reports on the status of nine companies in the Potent Compound Safety Certification Program.

SafeBridge Updates Potent API and Drug Manufacturer Status

Shimadzu has introduced the i-series of integrated HPLC and UHPLC systems. The analyzers meet the needs of any analytical environment with high speed, outstanding performance, maintainability and economic efficiency.

i-series - the new driver of i-volution in HPLC analysis

The new sizes follow the 2014 launch of the company’s fully disposable purifier.

3M Launches Production-Scale Sizes of its Upstream Purifiers

Charles Rivers strengthens its endotoxin testing and bacterial identification detection capabilities with the addition of Celsis’ products.

Charles River Acquires Celsis, Manufacturer of Rapid Microbial Detection Systems

Biologics exhibit greater variability in stability testing than do small-molecule drugs, and maintaining a stable test environment is crucial.

Testing the Stability of Biologics

James L. Brooks is a global quality control systems manager with Lonza Group Ltd.

Kurt In Albon is head of global IT quality Lonza Group Ltd.

Daniel Davis, PhD, is a global GMP compliance specialist with Lonza Group Ltd.

Heightened regulatory scrutiny of data integrity highlights the need for comprehensive procedural reviews and strategies for managing mission-critical information.

Analytics

Biologics Quality Control: The Growing Need for Accessible Proteomics

Emerging Therapies Drive Analytical Advancements

Analyzing Exabytes